1. Ultra Early Tumour Screening

      Background

      Malignant tumours is one of the top causes of death globally. In recent years, one person is diagnosed with a tumour every 6 minutes. The latest technology can detect and identify tumours from a blood sample. CBT’s preTes tumour screening system represents one of the world’s highly comprehensive and accurate gold standard tumour detection technology—circulating tumour DNA (ctDNA) technology, overcoming the challenge of detecting tumours in its precancerous state.

      Test Content

      preTes Ultra Early Tumour Screening can provide an early diagnosis from 3 to 5 years in advance from its cancerous stage.

      preTes covers nasopharyngeal carcinoma, chloangiocarcinoma, small cell lung cancer, liver cancer, osteosarcoma, melanoma, laryngeal cancer, acute myeloid leukemia, thyroid cancer, colorectal cancer, non-small cell lung cancer (NCLC), esophagus squamous cell carcinoma, bladder cancer, soft tissue tumour, kidney cancer, adrenal adenoma, esophageal adenocarcinoma, gastric cancer, pancreatic cancer, mediastinal tumour, Hodgkin's lymphoma, non-Hodgkin's lymphoma, gastrointestinal stromal tumour, urethral cancer, gallbladder cancer, myelodysplastic syndrome, prostate cancer, head and neck cancer, cervical cancer, ovarian cancer, breast cancer and endometrial cancer.

      Sampling Method

      10ml of blood (fasting state).
      Be smart. Decipher your genetic code and act to prevent before it is too late.

      Go Top
      国产在线 五月天激情电影,久久五月丁香中文字幕,亚洲 自拍色综合图区,亚洲中文精品第1页 国产二区,神马影院我不卡影院